SCHEMBL24301017

SCHEMBL24301017

Fc1cc(-c2ccc(C3CCCC3)cc2)ccc1-c1ccc(CC2CCCC2)s1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.41
▸ CYP2C9 P11712 2/20 0.38
▸ APP P05067 2/20 0.38
▸ S1PR4 O95977 1/20 0.33
▸ S1PR1 P21453 1/20 0.33
▸ S1PR5 Q9H228 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NOTUM Q6P988 2/20 0.32
▸ AAK1 Q2M2I8 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24301016 0.99 CYP3A4 (0.40) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24300687 0.99 CYP3A4 (0.40) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24301028 0.98 CYP3A4 (0.38) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24300686 0.98 CYP3A4 (0.38) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24300712 0.95 CYP3A4 (0.36) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24301022 0.88 CYP3A4 (0.39) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24301023 0.87 CYP3A4 (0.39) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24300710 0.87 CYP3A4 (0.39) CYP3A4CYP2C9APPS1PR4S1PR1
SCHEMBL24300963 0.87 ESR1 (0.35) AAK1KDM1A
SCHEMBL27027384 0.87 CYP3A4 (0.41) CYP3A4CYP2C9APPS1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068499-A1 THIOPHENE-CONTAINING LIQUID CRYSTAL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京八亿时空液晶科技股份有限公司 2022-04-07 — — WO disclosed
Send feedback